We have approved
this new FDA form with the following condition: FDA will submit for
OMB review a copy of any documents or guidance which clarify how
FDA will implement the user fee waiver provision.
Inventory as of this Action
Requested
Previously Approved
11/30/1996
11/30/1996
602
0
0
301
0
0
0
0
0
THE PRESCRIPTION DRUG USER FEE ACT
REQUIRES PHARMACEUTICAL COMPANIES T PAY FOR A FEE FOR EACH DRUG
APPLICATION/SUPPLEMENT SUBMITTED FOR APPROVAL. FORM PROVIDES A
MECHANISM TO DETERMINE WHETHER THE FEE SUBMITTED WITH APPLICATION
IS APPROPRIATE.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.